Cost-effectiveness of pneumococcal vaccination policies and uptake programs in US older populations

BACKGROUND/OBJECTIVES: Recently revised vaccination recommendations for US adults ≥65 years old include both pneumococcal polysaccharide vaccine (PPSV23) and pneumococcal conjugate vaccine (PCV13), with PCV13 now recommended for immunocompetent seniors based on shared decision making. The public hea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Geriatr Soc
Autors principals: Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K., Smith, Kenneth J.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7299822/
https://ncbi.nlm.nih.gov/pubmed/32086950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jgs.16373
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars